Protein transport across the lung epithelial barrier. - Wikidata - awgldk - TriplyDB

Protein transport across the lung epithelial barrier.

Protein transport across the lung epithelial barrier.

http://www.wikidata.org/entity/Q35047713

about

Silica coating influences the corona and biokinetics of cerium oxide nanoparticles Claudins: Gatekeepers of lung epithelial function Long-chain acyl-CoA dehydrogenase deficiency as a cause of pulmonary surfactant dysfunction Critical determinants of uptake and translocation of nanoparticles by the human pulmonary alveolar epithelium Physicochemical factors that affect metal and metal oxide nanoparticle passage across epithelial barriers Nanomaterial interactions with and trafficking across the lung alveolar epithelial barrier: implications for health effects of air-pollution particles Nanoparticle effects on rat alveolar epithelial cell monolayer barrier properties Mechanisms of alveolar epithelial translocation of a defined population of nanoparticles In vivo biocompatibility, clearance, and biodistribution of albumin vehicles for pulmonary drug delivery Characterization of protein factor(s) in rat bronchoalveolar lavage fluid that enhance insulin transport via transcytosis across primary rat alveolar epithelial cell monolayers Spontaneous lung dysfunction and fibrosis in mice lacking connexin 40 and endothelial cell connexin 43 Increased lungkine and chitinase levels in allergic airway inflammation: a proteomics approach.Clathrin-mediated endocytosis of FITC-albumin in alveolar type II epithelial cell line RLE-6TN.Indication of transcytotic movement of insulin across human bronchial epithelial cells.Comparison of fluorescence-based methods to determine nanoparticle uptake by phagocytes and non-phagocytic cells in vitro.Streptococcus pneumoniae Interacts with pIgR expressed by the brain microvascular endothelium but does not co-localize with PAF receptor Surface functionality of nanoparticles determines cellular uptake mechanisms in mammalian cells.Light-dark oscillations in the lung transcriptome: implications for lung homeostasis, repair, metabolism, disease, and drug action.Differential effects of claudin-3 and claudin-4 on alveolar epithelial barrier function.Is there a regulatory role of immunoglobulins on tissue forming cells relevant in chronic inflammatory lung diseases?Evaluation of lung injury in rats and mice.Mechanisms of alveolar protein clearance in the intact lung.The Lung-Liver Axis: A Requirement for Maximal Innate Immunity and Hepatoprotection during Pneumonia.Inhibition of CD23-mediated IgE transcytosis suppresses the initiation and development of allergic airway inflammation.Pulmonary delivery of interleukin-7 provides efficient and safe delivery to the aging immune system Antigen-specific regulation of IgE antibodies by non-antigen-specific γδ T cells.Immortalization of human alveolar epithelial cells to investigate nanoparticle uptake.Mammalian cells preferentially internalize hydrogel nanodiscs over nanorods and use shape-specific uptake mechanisms.Combined computational and experimental studies of molecular interactions of albuterol sulfate with bovine serum albumin for pulmonary drug nanoparticles.Regulation of caveolin-1 expression and phosphorylation by VEGF in ovine amnion cells.Nanocarriers for pulmonary administration of peptides and therapeutic proteins.Challenges in development of nanoparticle-based therapeutics.Inhaled biopharmaceutical drug development: nonclinical considerations and case studies.Intracellular delivery of polymeric nanocarriers: a matter of size, shape, charge, elasticity and surface composition.Novel concepts of acute lung injury and alveolar-capillary barrier dysfunction.Bioavailability of therapeutic proteins by inhalation--worker safety aspects.Receptor-mediated endocytosis of macromolecules and strategy to enhance their transport in alveolar epithelial cells.Exploration of the normal human bronchoalveolar lavage fluid proteome.Protective effects of chebulic acid on alveolar epithelial damage induced by urban particulate matter Expanding analytical options in sports drug testing: Mass spectrometric detection of prohibited substances in exhaled breath.

P2860

Q23918710-A071449D-3130-4A08-BA8B-CB84F833DE6E Q26828514-2BE6571C-EAF2-4FEE-84FE-863C6FD92E43 Q28308215-5941F59D-F23B-4FAB-8CFB-6751E58952D3 Q28383130-2D5CD0E9-9DA7-4008-AED6-D57BC554AA48 Q28384922-27A52698-AA04-40CE-B855-0943BBA413DC Q28385393-E5BED6FD-946C-4C31-B639-17E44FA0B40E Q28392424-8467D7BD-5057-43D1-BA6C-82172D1C0ACE Q28395780-550A7A17-8DF3-47CD-AD99-4093A20E671F Q28396006-8869C124-9B34-45DE-BE34-AB7DC397A403 Q28397450-88E2521B-A067-4179-B8EF-C5DF2DA06D78 Q30426561-16D3F46D-3FDD-4D4C-A0C5-9D8C4CBF45E2 Q30790147-0D1ED9E1-3EA9-4AE8-A3BF-A97F6A74BD1C Q33229789-3F5FB1E2-4B23-40CD-BD80-E639EE49158A Q33246890-209AEC33-D3A3-4042-9E2C-A058FC21D87B Q33618992-81FA20C5-340D-40D4-865D-B91EEF52FD46 Q33632794-EA77457A-7014-42A0-AF11-983761F52F3D Q33804603-7C3F5CA5-6AE6-405F-8908-4ACB11558510 Q35057088-46EFE6C8-B52C-4EE7-AC89-C15F3E0150C8 Q35087018-CF760420-3218-4368-8BEF-7203727588A4 Q35550738-C47F5241-578F-486F-85CF-03B7356A223E Q35623595-54E32CB6-A37B-4722-A2DB-296849369715 Q35683691-A008AE4B-23AD-4180-8774-5E8B1566B752 Q36049265-92C92085-64AA-48FD-BB27-25F458ECEBE2 Q36073168-7C2F5509-4DAA-473D-90DC-29BB82DC0249 Q36166467-D83BAFA8-F58F-48FA-9A93-2C8A799FA873 Q36553768-ECC4E65D-1F6E-448E-B8BD-B13DFDB482AE Q37098457-B326F447-D8D5-4AE9-AC02-0204B4056254 Q37255871-1187B63B-E6B7-4064-9F50-0DC88763C58D Q37269769-FF4ED727-EB79-4A60-A967-538A2A618DB4 Q37662176-86556DBF-60BF-49CC-A2AA-5FDAF3ED81D5 Q37823598-7A1BF203-5ED8-4774-8DC6-15DD5E19B267 Q37992525-FEA2A935-4A62-4AC4-A41F-E76D55F5DAC4 Q38088303-81E40645-BD85-46ED-8DB0-DFE4BCC1F04E Q38112171-B2010C86-0906-4296-B98A-734A9AE97ADF Q38138015-12237C10-FC76-4F62-9F9A-EBCBF3DFB36E Q38222723-D992A9FB-DA5C-4E49-A841-24AA07A55F8D Q38286395-F7F86B2D-8BCE-40E7-B721-A66C8B12DE58 Q38514151-C6E97DCF-1617-487C-B8DE-1EBC19935B85 Q38671651-6EA3885F-9535-41A2-A1B8-CE0CDB153017 Q38683380-67BA7DA1-66E1-49ED-87D8-BA8976E1E5FA

P2860

Protein transport across the lung epithelial barrier.

http://www.wikidata.org/entity/Q35047713

description

2003 nî lūn-bûn

@nan

2003 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Protein transport across the lung epithelial barrier.

@en

type

label

Protein transport across the lung epithelial barrier.

@en

prefLabel

Protein transport across the lung epithelial barrier.

@en

P1433

Q35047713-DF8B9E80-460C-4EC3-8B9A-9729AB31D73D

P1476

Q35047713-1A27304E-8561-4466-A110-D6464D045333

P2093

Q35047713-242200DF-5C8F-424D-95DF-0BBFDA55526D

Q35047713-5FA6FCA7-4D1E-4880-A81C-198D8ADFD01F

P2860

Q35047713-04EC46A0-60E1-4F05-885E-DE39055AC6B1

Q35047713-0B71729F-C220-4AE4-99D7-5BB3ECC65FD7

Q35047713-0C6AB19E-9F72-4EFA-B018-8FA44D90AC20

Q35047713-0C7E5F30-D43D-487B-8539-46AF63826C53

Q35047713-0E6912C3-1B25-4BF7-864F-39DEE92A9C01

Q35047713-12DE396C-2240-49B2-B554-F24E0006ADAC

Q35047713-175C9758-8780-4317-9B30-51E236313C88

Q35047713-1ADC31F0-2555-47F9-811E-9D014B4E8127

Q35047713-1ED0B127-964C-4905-B6ED-EA17EDD4FE28

Q35047713-2026267B-9CD6-4F90-8225-96B5BAFCCE2B

P304

Q35047713-CB2E5907-C4EB-4ECB-B956-BE0E15EACABD

P31

Q35047713-64FD7B8B-B59A-407F-8141-DAA7C707E3E6

P356

Q35047713-B2C5CE74-0812-494B-A28E-88F2BA7E839C

P433

Q35047713-2CB16AD6-06D3-4E4C-845B-1139A7A0E3A5

P478

Q35047713-AB0E0470-CF40-46D0-9FDE-0F7D31CA2D12

P577

Q35047713-BCAAF5DE-D3E2-4D25-A710-75C9ABCCDDA9

P5875

Q35047713-25A5CEB8-14EF-408D-B2DB-2B8195B08E00

P698

Q35047713-20CCB690-DF5C-4186-9C35-4DCEE056A7CC

P356

AJPLUNG.00235.2002

P1433

American Journal of Physiology - Lung Cellular and Molecular Physiology

P1476

Protein transport across the lung epithelial barrier.

@en

P2093

Asrar B Malik

http://www.w3.org/2001/XMLSchema#string

Kwang-Jin Kim

http://www.w3.org/2001/XMLSchema#string

P2860

Dynamics of immunoglobulins at the feto-maternal interface

Evidence for the role of alveolar epithelial gp60 in active transalveolar albumin transport in the rat lung

Cloning, characterization, and development expression of a rat lung alveolar type I cell gene in embryonic endodermal and neural derivatives

An Fc receptor structurally related to MHC class I antigens

Loss of caveolae, vascular dysfunction, and pulmonary defects in caveolin-1 gene-disrupted mice

Evidence of transcellular permeability pathway in microvessels.

Caveolin and its cellular and subcellular immunolocalisation in lung alveolar epithelium: implications for alveolar epithelial type I cell function.

Isolation and characterization of a cell surface albumin-binding protein from vascular endothelial cells

Bidirectional FcRn-dependent IgG transport in a polarized human intestinal epithelial cell line

Aquaporin water channels and lung physiology.

P304

L247-59

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1152/AJPLUNG.00235.2002

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

284

http://www.w3.org/2001/XMLSchema#string

P577

2003-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

10946563

http://www.w3.org/2001/XMLSchema#string

P698

12533309

http://www.w3.org/2001/XMLSchema#string